pyrazines and eye
pyrazines has been researched along with eye in 4 studies
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hirata, H; Oshinsky, ML | 1 |
| Chen, DQ; Li, P; Ma, PK; Mu, HJ; Sun, KX; Wei, JH | 1 |
| Cardona, DM; Cardones, AR; Chao, NJ; Chen, BJ; Di Paolo, JA; Jia, W; Kim, JY; Perez, VL; Poe, JC; Reyes, NJ; Saban, DR; Sarantopoulos, S; Su, H; Sundy, JS | 1 |
| Ayıntap, E; Aytogan, H; Doran, MA | 1 |
Other Studies
4 other study(ies) available for pyrazines and eye
| Article | Year |
|---|---|
Ocular dryness excites two classes of corneal afferent neurons implicated in basal tearing in rats: involvement of transient receptor potential channels.
Topics: Acetanilides; Action Potentials; Analysis of Variance; Animals; Cornea; Disease Models, Animal; Dose-Response Relationship, Drug; Dry Eye Syndromes; Eye; Male; Mannitol; Neurons, Afferent; Osmolar Concentration; Purines; Pyrazines; Pyridines; Rats; Rats, Sprague-Dawley; Reaction Time; Stimulation, Chemical; Tears; Temperature; Transient Receptor Potential Channels; Vision, Ocular | 2012 |
[Study on preparation of ligustrazine ocular implant and correlation between in vivo and in vitro drug release].
Topics: Animals; Biological Availability; Drug Implants; Eye; Female; Male; Polyglycolic Acid; Pyrazines; Rabbits; Vitreous Body | 2013 |
SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.
Topics: Administration, Oral; Animals; B-Lymphocytes; Disease Models, Animal; Drug Evaluation, Preclinical; Eye; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Indazoles; Mice; Protein Kinase Inhibitors; Pyrazines; Skin; Survival Analysis; Syk Kinase; T-Lymphocytes; Treatment Outcome | 2018 |
Fluorescence of ocular surface in a Covid -19 patient after Favipiravir treatment: a case report.
Topics: Adult; Amides; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Eye; Fluorescence; Humans; Male; Pyrazines; SARS-CoV-2 | 2021 |